Current role
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Moleculin Biotech, Inc. (MBRX)
Proxy statement
Current -
CNS Pharmaceuticals, Inc. (CNSP)
Proxy statement
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Current role
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Moleculin Biotech, Inc. (MBRX) | Chief Scientific Officer | $340,000 | $622,919 |
| 2024 | Moleculin Biotech, Inc. (MBRX) | Chief Scientific Officer | $340,000 | $694,062 |
| 2023 | Moleculin Biotech, Inc. (MBRX) | Chief Scientific Officer | $340,000 | $599,106 |
| 2022 | Moleculin Biotech, Inc. (MBRX) | Chief Scientific Officer | $340,000 | $699,469 |
| 2021 | Moleculin Biotech, Inc. (MBRX) | Chief Scientific Officer | $323,333 | $682,397 |
| 2020 | Moleculin Biotech, Inc. (MBRX) | Chief Scientific Officer | $300,000 | $520,327 |
| 2019 | Moleculin Biotech, Inc. (MBRX) | Chief Scientific Officer | $289,583 | $522,189 |
| 2018 | Moleculin Biotech, Inc. (MBRX) | Chief Scientific Officer | $254,167 | $439,407 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.